Genomics Firms Tackle Carbon Emissions, Face Obstacles to Net-Zero Goals From Suppliers, Shipping
Proposed SEC rules about emissions reporting are spurring companies to act, but carbon reductions could be offset by growth and lack of control over the supply chain.
Former Precipio CFO, Son Agree to Settle SEC Insider Trading Lawsuit
Former Precipio CFO Carl Iberger was charged with providing confidential information regarding a company distribution deal for a COVID-19 test.
CareDx Q3 Revenues Grow 42 Percent; Firm Discloses Investigations by DOJ, SEC
The molecular diagnostics company reported $75.6 million in revenues for the quarter and said testing service revenues rose 46 percent year over year.
Cue Health Files for IPO for up to $100M
The company developed its portable Cue Integrated Care Platform for molecular SARS-CoV-2 testing and received an EUA for its test in June 2020.
Talis Biomedical 2020 Revenues Rise Sharply
The company also said it is planning on filing for Emergency Use Authorization for its SARS-CoV-2 test in the second quarter of 2021.